Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Akorn Pharmaceuticals

02 1Amphastar Pharmaceuticals

03 2Bausch & Lomb Incorporated

04 7Centocor

05 1Central Procurement & Supplies Unit

06 2Genentech

07 1Halozyme Therapeutics

08 1Pinewood Healthcare

09 6Takeda Pharmaceutical

10 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE

Brand Name : HYDASE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150 UNITS/ML

Packaging :

Approval Date :

Application Number : 21716

Regulatory Info :

Registration Country : USA

blank

02

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE

Brand Name : AMPHADASE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150 UNITS/ML

Packaging :

Approval Date :

Application Number : 21665

Regulatory Info :

Registration Country : USA

blank

03

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE

Brand Name : VITRASE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 6,200 UNITS/VIAL

Packaging :

Approval Date :

Application Number : 21640

Regulatory Info :

Registration Country : USA

blank

04

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE

Brand Name : VITRASE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 200 UNITS/VIAL

Packaging :

Approval Date :

Application Number : 21640

Regulatory Info :

Registration Country : USA

blank

05

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

DARATUMUMAB AND HYALURONIDASE-FIHJ

Brand Name : DARZALEX FASPRO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG;2000UNITS/ML

Packaging :

Approval Date :

Application Number : 761145

Regulatory Info :

Registration Country : USA

blank

06

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : INJECTION

Dosage Strength : 10ML

Packaging :

Approval Date :

Application Number : 761433

Regulatory Info :

Registration Country : USA

blank

07

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : INJECTION

Dosage Strength : 14ML

Packaging :

Approval Date :

Application Number : 761433

Regulatory Info :

Registration Country : USA

blank

08

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 1,600MG/20,000 UNITS PER 10ML

Packaging :

Approval Date :

Application Number : 761484

Regulatory Info :

Registration Country : USA

blank

09

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 2,240MG/28,000 UNITS PER 14ML

Packaging :

Approval Date :

Application Number : 761484

Regulatory Info :

Registration Country : USA

blank

10

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 2,400MG/30,000 UNITS PER 15ML

Packaging :

Approval Date :

Application Number : 761484

Regulatory Info :

Registration Country : USA

blank

11

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

AMIVANTAMAB AND HYALURONIDASE-LPUJ

Brand Name : RYBREVANT FASPRO

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 3,5200MG/44,000 UNITS PER 22ML

Packaging :

Approval Date :

Application Number : 761484

Regulatory Info :

Registration Country : USA

blank

12

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 1,200MG;600MG;30,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

13

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 600MG;600MG;20,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

14

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE RECOMBINANT HUMAN

Brand Name : HYLENEX RECOMBINANT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150 UNITS/ML

Packaging :

Approval Date :

Application Number : 21859

Regulatory Info :

Registration Country : USA

blank

15

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Hyaluronidase

Brand Name : Hyalase

Dosage Form : Powder For Solution For Injection And Infusion

Dosage Strength : 1500IU/ML

Packaging :

Approval Date : 2006-08-23

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank

16

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Hyaluronidase; Normalt Immunoglobulin Til Intravenøs Brug; Humant

Brand Name : Hyqvia

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 16-05-2013

Application Number : 28104990111

Regulatory Info : Prescription

Registration Country : Denmark

blank

17

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE (HUMAN RECOMBINANT)

Brand Name : HYQVIA

Dosage Form : SOLUTION

Dosage Strength : 200UNIT/1.25ML

Packaging :

Approval Date :

Application Number : 2524368

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

18

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE (HUMAN RECOMBINANT)

Brand Name : HYQVIA

Dosage Form : SOLUTION

Dosage Strength : 400UNIT/2.5ML

Packaging :

Approval Date :

Application Number : 2524376

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

19

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

HYALURONIDASE (HUMAN RECOMBINANT)

Brand Name : HYQVIA

Dosage Form : SOLUTION

Dosage Strength : 800UNIT/5ML

Packaging :

Approval Date :

Application Number : 2524384

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

20

Central Procurement & Supplies Unit

Country
Sampe
Not Confirmed
arrow

Central Procurement & Supplies Unit

Country
arrow
Sampe
Not Confirmed

Hyaluronidase

Brand Name : Hyalase

Dosage Form : Powder For Solution For Injection And Infusion

Dosage Strength : 1500IU

Packaging :

Approval Date : 2019-04-29

Application Number :

Regulatory Info : Invalid

Registration Country : Malta

blank